THE EFFICACY OF LOW DOSE NALTREXONE THERAPY IN CHILDREN WITH CROHN'S

低剂量纳曲酮治疗克罗恩病儿童的疗效

• 批准号: 7951293
• 负责人: Jill P Smith
• 金额: $ 1.62万
• 依托单位: PENNSYLVANIA STATE UNIV HERSHEY MED CTR
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-04-01 至 2010-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7951293
• 关键词: Child; Childhood; Clinical Research; Computer Retrieval of Information on Scientific Projects Database; Crohn' s disease; Cross-Over Studies; Dose; Double-Blind Method; Funding; Grant; Institution; Naltrexone; Patients; Placebo Control; Randomized; Research; Research Personnel; Resources; Source; United States National Institutes of Health; cohort

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The investigators hypothesize that low dose naltrexone therapy will be effective in the treatment of pediatric patients with Crohn's disease. In order to examine this hypothesis, they propose to investigate the effects of low dose naltrexone on a cohort of thirty patients with active Crohn's disease in a randomized double-blind placebo controlled cross-over trial.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 研究人员假设低剂量纳曲酮治疗将有效治疗克罗恩病的儿科患者。为了审查这一假设，他们建议研究低剂量纳曲酮对30例活跃克罗恩病的队列的影响。